# Breaking the Diagnostic Barrier: DNAJB9 Heat Shock Protein Testing for Fibrillary Glomerulonephritis in Cases With Low Tissue Reserves

## TL;DR

This paper describes a case where DNAJB9 heat shock protein testing helped diagnose a rare kidney disease called fibrillary glomerulonephritis in a patient with limited tissue for testing.

## Contribution

The study highlights the use of DNAJB9 testing as a diagnostic tool for FGN in cases with low tissue reserves.

## Key findings

- DNAJB9 heat-shock protein was detected in the patient's tissue, supporting a diagnosis of fibrillary glomerulonephritis.
- FGN has a poor prognosis, with a 50% chance of progressing to end-stage renal disease within 10 years.
- Early detection and proper care are crucial for improving outcomes in FGN patients.

## Abstract

Fibrillary glomerulonephritis (FGN) is an uncommon primary glomerular condition with a vague clinical presentation that poses a diagnostic challenge. We present a case of a 73-year-old white female with severe kidney damage, malignant hypertension, and recurring abdominal pain who underwent a series of extensive tests until her renal biopsy showed eosinophilic deposits with mesangial matrix and GBM growth, indicating segmental membranoproliferative characteristics, and global mesangial proliferation of the glomeruli with fibrillary deposits. The DNAJB9 heat-shock protein was present in the tissue sample, supporting the FGN diagnosis. The lack of clear-cut treatment standards makes managing FGN difficult, and the disease has a dismal prognosis with a 50% possibility of developing end-stage renal disease within an average of 10 years post-diagnosis. Improving patient outcomes and halting further decline in renal function depend on early detection and effective care.